Wednesday, 14 October 2020

Two Eli Lilly's COVID-19 studies testing remdesivir, experimental antibody therapy paused due to safety issues


via Firstpost Tech Latest News https://ift.tt/3iUMlXt
Previous Post
Next Post

post written by:

0 comments: